GWHT collaborates with clinicians, researchers, and global health organizations to deploy technologies across its core clinical programs in cervical and breast cancer. These partnerships span community clinics, hospitals, and global health systems, enabling technologies to be implemented in diverse healthcare environments.

These collaborations support the evaluation of innovations in real clinical settings and enable the expansion of access to screening, detection, and treatment technologies.

Community partnerships play a critical role in screening programs and implementation initiatives, particularly in cervical cancer prevention and breast cancer care, helping to address disparities in access and outcomes.

These collaborations ensure that technologies are grounded in real patient needs, clinical workflows, and the operational realities of healthcare delivery.
Through these partnerships, GWHT ensures that technologies developed through research are tested, adapted, and integrated into healthcare systems—translating innovation into meaningful improvements in patient outcomes.

Partnerships also provide critical training environments for students and fellows. Through programs such as Duke Ignite and the Translational Fellows Program, participants engage directly with community and clinical partners, building the skills needed to translate engineering solutions into real-world healthcare impact.